ost of us have a strong desire to publish our fi ndings, to present our results and to share our experiences with others working in the fi eld. Perhaps it isn't quite true that everyone has a book inside them, but there may be a good research paper that presents our research interests and experiences, and our ideas, in a way that can be critically assessed by others who may moderate their own practice based on our fi ndings. Research is the bedrock of evidence-based practice and the fuel for developments in safe and effective care. It is the evidence that underpins strategy, development, practice and regulation. For every one of us a strong publication record, measured in quality rather than quantity, can open doors and enhance career prospects while publication provides a tangible measure of professional achievement that is central to professional career development.
Do not be put off by the challenges ahead. Good quality research takes time. Few of us are lucky enough to have a Eureka moment that is truly lucid and complete. Ideas take time to formulate properly. A clear research plan is essential, with a rigorous and properly documented methodological approach. A thorough review of the existing literature and discussions with senior colleagues will improve the research plan and may identify better or more appropriate lines for investigation or approaches to study. If statistical analysis is going to be necessary consult a professional statistician before, not after, the study begins in order that the study design can be optimised for statistical evaluation.
Ethical and fi nancial issues are particularly important and deserve special mention. Research involving study on humans must conform to the World Medical Association Declaration of Helsinki and its ethical principles for research involving human subjects (World Medical Association, 2008) . Research that fails to adhere to these standards will be immediately rejected. Any research proposal that involves the use of patient details or variation of a treatment regimen will require the full scrutiny of a local ethics committee, and researchers must secure written approval before work starts. This can be tricky and is perhaps the fi rst real hurdle, though it is also an opportunity to have your research plan critically reviewed by others. Your friends and colleagues may have been sympathetic and supportive when reading your research proposal, but ethics committee review will be a much greater challenge that will nonetheless provide an invaluable learning experience that inevitably improves your study proposal. If the work has commercial impact, now is the time to seek professional assistance and obtain protection for your idea and secure the opportunity to exploit the outcome of your research. Studies involving new pharmaceutical agents, medical products or devices not appearing in the local approved formulary or specifi ed in protocols for regular fi rst-line use will require formal approval from the local Drugs and Therapeutics Committee or equivalent.
Other ethical considerations apply. Researchers have an obligation to ensure that material resources and any fi nancial support that they have received are used wisely, considering also those who may invest in future research projects that rely heavily on your results. Unethical research behaviour suffi ciently serious to warrant disciplinary action or sanctions from academic institutions and journals regrettably still occurs. Editors and publishers will do everything possible to identify and eradicate this -the Committee of Publication Ethics VOL. 11 NO. 2 MARCH 2010 Journal of Infection Prevention 33 (COPE) states that 'Editors [together with the editorial panel and referees] have a prime duty to maintain the integrity of the scientifi c record' and 'do their utmost to identify publication misconduct in submitted and published articles' (COPE, 2008) . The highest standards of probity are required also of the journal team with a parallel ethical commitment for the editor and editorial board, referees and the publisher, to consider every submission on merit alone. Confi dentiality is assured. A successful journal will fl ourish because of the quality of its content, which refl ects the activities and standards of the editor and editorial board, and of the referees.
When all the results are in, researchers will be keen to prepare a draft manuscript with a view to publication. Without doubt, that draft will be the fi rst of many. Consult with colleagues. Perhaps test the interpretation of your data at a local meeting. You might consider submission of an abstract to a suitable conference, though there too you will be expected to present a fully polished presentation. Prior publication of results in Conference Proceedings does not preclude a substantive publication but please do record detail of any presentation as a footnote to the manuscript. Check carefully that the manuscript conforms closely to the style and formatting requirements of the journal, paying particular attention to the accuracy of all references. Be careful to obtain written consent for the reproduction of imaging studies, making certain that patient identifi ers are obliterated. Patient photography must comply with local rules and must always include formal written consent. Units of measurement, abbreviations and the layout and structure of the manuscript must conform precisely to the journal requirements though where necessary the overall structure of a manuscript can vary, for example for reviews, case and outbreak reports, commentaries and opinion papers, and correspondence items. Serious errors at this stage may result in immediate rejection, no matter how good the research might have been. Though the editors will be happy to help you at this stage, it is not their role to re-evaluate your data and rewrite your results, to change tables and fi gures, moderate your discussion and conclusions, or to correct the references! For some, assistance may be required in grammar and spelling. Authorship is an often contentious issue. Have all authors made a signifi cant contribution to the work? Overall, about one fi fth of authors with their names on top of a published paper have made little or no contribution, while junior researchers who have done much of the work may be excluded from authorship. Authorship should be considered at the outset as part of the original research plan. Additional authors can be included as required, for example those who have been co-opted during the study and have made a signifi cant contribution to the study, while others whose contribution has been less may receive an acknowledgement at the end of the manuscript.
Once a manuscript is submitted, the journal editor will face many challenges. Does the subject match the aims of the journal? The aim and scope of the Journal of Infection Prevention (JIP) is to advance the evidence base in infection prevention and control, and to provide a publishing platform for all health professionals interested in this fi eld of practice. It is entirely appropriate therefore that the editor, editorial panel, referees and publisher each measure against this standard but the scope is wide and we will be delighted to receive submissions under this broad banner, no matter how diverse.
On receipt of your submission, the editor must consider if this is original and high quality research. Does it offer new information, or merely repeat existing observations? This is not of itself a reason for rejection because confi rmation of earlier original observations can be particularly important. More fundamental questions must also be addressed. Does the work meet mandatory ethical standards? Is there evidence of plagiarism, or of duplicate publication? If all appears well, the editor will invite independent referees to examine the manuscript. Referees will be selected for their experience in a particular fi eld and editors will generally invite at least two and sometime three reviewers to examine each manuscript to ensure diversity of opinion and to eliminate bias. Referees will usually be drawn from a panel of senior practitioners, researchers, scientists and others, all of whom have particular experience in their fi eld. They will always be detached from the study and host institution, and must declare immediately any potential confl ict of interest. To ensure properly blinded peer review, referees will be unaware of the identity of the author(s) and their host institution as that information will be stripped from the manuscript before distribution. This is a two-way process, and the referees will not be identifi ed to authors.
Referees must be impartial in their examination of submitted manuscripts. The referees' role is to provide specialist advice to the editor, mainly regarding the quality of the research and the standard of presentation of the manuscript. If necessary, referees or peer reviewers will offer specifi c advice regarding improvements in style and presentation and can suggest improvements or identify weaknesses that require additional work, but the onus is on the author(s) to meet these challenges and if necessary revise and re-present their manuscript. On occasions, authors may receive starkly confl icting demands for change from the two referees, both of which sit uneasily with their own ideas. Have no fear in challenging these demands though challenges must be properly justifi ed and clearly explained in a covering letter because such occurrences often point to ambiguity in experimental design or interpretation that has caused confusion with referees and will similarly confuse the wider readership unless corrected.
Referees and editors are generally busy people with full time jobs in addition to these additional duties and cannot, and generally will not, provide extensive and detailed assistance to rewrite a fundamentally defective manuscript. Most referees will quickly detect submissions that are grossly incomplete or inadequate and for these submissions rejection is likely. If this happens to you, you can expect an explanation that should identify problem areas and give a pointer to opportunities for improvement that may guide supplementary study and eventual re-presentation of your manuscript. For manuscripts showing promise, immediate acceptance is unlikely as almost always there will be need for some clarifi cation or correction or some further improvement. For other manuscripts, more extensive work may be required and referees will offer clear guidance and reasoning for their concerns, with an invitation to resubmit a revised manuscript within a few weeks or months depending on the nature of the revisions required.
Be prepared for some diffi cult questions. Referees will search for incomplete or inconsistent data and may expect greater detail and additional clarifi cation, or a shorter and more succinct presentation. The referees' view of clarity may differ from that of the author(s). What does 'ordinary' mean, defi ne 'regular', how normal is 'normal', what is 'usual', or 'average' or 'typical'? Graphs and charts must be clear and unambiguous and should assist the reader in interpretation of your data. They are not for decoration and authors must consider the value of every illustration since data presented in the text should not be repeated in tables or fi gures. A particularly common error is a failure to address some earlier but highly relevant publications especially where this is contradictory to the current fi ndings, or to misquote references and take the fi ndings of others out of their intended context. It is perfectly acceptable to express a different opinion or to move away from established theory, but to do so needs the backing of a meticulously presented hypothesis, sound reasoning and almost certainly a substantial body of rigorously conducted experimental evidence to support an alternate hypothesis. Do make certain that all experimental data is properly documented and retained for scrutiny, even after publication of your manuscript.
For some, a fully rounded research study that embraces and provides proof of an original hypothesis will not be possible but this does not preclude publication. The Journal of Infection Prevention provides ample opportunity to share your ideas and to present the results of pilot studies since these too will be of interest and may assist others in the formulation of their own more detailed studies. Perhaps surprisingly, there can also be a place for negative fi ndings because these may prevent others from making the same mistakes or embarking on a study that is destined to fail.
An important aspect of the publishing process is the declaration of any funding or other sponsorship, and of any confl ict of interest. Think carefully about this. Who provided funding for the work? Was there any input from commercial sponsors? Who provided the study materials? What links exist between the authors and those who may have a commercial interest in the results? Funding and sponsorship must be declared as an endnote to the manuscript, not least as a note of thanks. Studies that rely on the supply of free samples of a new wonder product may give pleasingly impressive results, but what about other (competitor) products that have not been tested? Did you compare against the accepted 'gold standard'? What about that over-generous funding to attend a conference or present a paper based on your results, or help with the analysis of data and statistical review that was most welcome at the time but which, on refl ection, started way back at the design stage of a project? There are lessons for each and every one of us. It is easy to say that no confl ict exists, but what about the supply of goods or those discussions with a company representative who was so helpful in suggesting an approach to study, and later to the approach to interpretation of the results obtained, because in the eyes of others this may be an unacceptable infl uence. A full and open declaration is the correct approach, so that readers can make their own fully informed decision.
At every stage, the editor and referees will be diligent to the possibility of research fraud. Plagiarism is totally unacceptable, and though the work of others can and probably will be cited in your own manuscript, this should be properly referenced. Simply copying the work of others is totally unacceptable and though it is a rare event and happens in extreme cases, it can result in an investigation that may involve the editorial board liaising with the senior offi cers of the authors' host institution or professional body. Duplicate publication is similarly unacceptable, though regrettably this still occurs as authors play the 'numbers game' to increase the number of publications and expand their Curriculum vitae. This distorts or skews the literature and misleads fellow researchers. Research fraud is a serous matter. Even if it escapes detection during the rigorous refereeing process, the eagle-eyed scrutiny of the Journal readership may identify issues not previously apparent leading to investigation and formal retraction even years later.
Despite all of these very many hurdles, some proportion of submitted manuscripts will move forward to publication. Take care with the fi nal preparation of typescripts and check proofs with the greatest of care. This is the last chance to correct any errors or inaccuracies, but it is not a time to introduce new material. And then, fi nally, your paper is published. Only then is it time to sit back with pride at your success in overcoming all of the very many hurdles that must be faced when considering scientifi c publication. But self-congratulation cannot last for too long as the next research project may already be in progress and we at the Journal of Infection Prevention will look forward to your next submission.
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